Own a part of our business. Capital at Risk.
View our pitch
Stablepharma completes the first close of Series A raise with £2 million following a number of high-profile partnership announcements
Alan Boyd, of Boyd Consultants & Advisor to Stablepharma, talks about his work, collaborations and the impact of the Pandemic
Özgür Tuncer CEO talks about Developing Thermostable Vaccines To Improve Accessibility Worldwide
Stablepharma partners with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology
Stablepharma appoints Professor Saul Faust to the Advisory Board
Stablepharma awarded £50,000 as part of UK research and innovation program
Stablepharma and BB-NCIPD collaborating on Td vaccine
Can chemistry thaw the vaccine cold chain?
Innovate UK Smart Grant awarded to vaccine stabilising company
StablevaX™ United States of America patent granted!
Dr. Bruce Roser featured in a recent Pharma Technology article on Pandemic Logistics